U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191756) titled 'Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study' on Sept. 17.
Brief Summary: Background:
Mucormycosis is a serious but rare fungal infection that requires rapid and effective treatment. The two main antifungal medicines used are amphotericin B and isavuconazole. However, more real-world data is needed to directly compare how well they work and how safe they are for patients.
What is the purpose of this study? The main goal of this research study is to compare the effectiveness and safety of amphotericin B versus isavuconazole in treating mucormycosis. Investigators will look at which ...